Pharmacological characterization of adrenergic alpha and beta receptors mediating the vasomotor responses of cerebral arteries in vitro.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D002415:Cats; D002536:Cerebral Arteries / Q000294:innervation*; D003983:Dibenzylchlorethamine / Q000494:pharmacology; D004147:Dioxins / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008433:Mathematics; D009638:Norepinephrine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011941:Receptors, Adrenergic; D013726:Terbutaline / Q000494:pharmacology; D014666:Vasomotor System / Q000187:drug effects*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D004147:Dioxins; D010880:Piperidines; D011941:Receptors, Adrenergic; D010643:Phenoxybenzamine; D003983:Dibenzylchlorethamine; D011433:Propranolol; D007545:Isoproterenol; D013726:Terbutaline; D009638:Norepinephrine; D004837:Epinephrine